Primidone Tablets Recall Due to Cross Contamination
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Golden State Medical Supply Inc. is recalling 8,526 bottles of Primidone Tablets, USP, 50 mg due to cross contamination with trace amounts of Acemetacin API.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on June 10, 2026 and geographically references United States. Its severity classification of "low" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Drugs.
What Happened
Golden State Medical Supply Inc. initiated a voluntary recall of Primidone Tablets, USP, 50 mg after the active pharmaceutical ingredient was found to be contaminated with trace amounts of Acemetacin API due to cross contamination with other products.
Which Products Are Affected
The recall covers Primidone Tablets, USP, 50 mg, 50-count bottles (NDC 51407-637-05), RX only, manufactured by Lannett Company, Inc. and marketed by GSMS, Incorporated. Affected lots include GS066750, GS067084, GS067710, GS067873 (Exp 3/31/2028) and GS068339, GS068897 (Exp 8/31/2028). A total of 8,526 bottles were distributed nationwide in the United States.
What You Should Do
Consumers should contact their physician or pharmacist regarding use of the affected product. For questions about the recall, contact Golden State Medical Supply Inc. at their Camarillo, CA facility.
Why This Matters
This Class III recall addresses a product quality issue involving trace cross contamination in a prescription anti-epileptic medication distributed across the United States.
Source
FDA recall D-0534-2026. https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,182 characters here).
Similar severity timing
Same severity (low) notices issued closest in time to June 10, 2026.
Frequently Asked Questions
Common questions about this FDA recall.